PDIA3 and cancer: Recent studies have shown that PDIA3 is upregulated in various cancers, including breast, prostate, ovarian, glial cell carcinoma, and cervical adenocarcinoma, and is involved in their development, progression, and response to chemotherapy (12, 13).